Showing results (1-10 of 1,558) with videos related to
Sort By:
Pageof 156
Contemporary Clinical Trials Communications|November 30, 2023
A promising biomarker adaptive Phase 2/3 design - Explained and expandedCong Chen, Linda Sun, Xuekui ZhangPharmaceutical Statistics|September 26, 2025
Adjustment for Inconsistency in Adaptive Phase 2/3 Designs With Dose OptimizationCong Chen, Mo Huang, Xuekui ZhangContemporary Clinical Trials|August 19, 2025
Adaptive phase 2/3 design with dose optimizationCong Chen, Mo Huang, Xuekui ZhangContemporary Clinical Trials|July 14, 2023
Framing the statistical criteria for accelerated approval of oncology drugs: A pathway for front runnersCong Chen, Linda SunStatistical Methods in Medical Research|June 1, 2026
Bayesian adaptive design for clinical trials with potential subgroup effectsXuekui Zhang, Qianyun Zhao, Cong Chen, et al.Journal of Biopharmaceutical Statistics|February 27, 2013
Evaluation of early efficacy endpoints for proof-of-concept trialsCong Chen, Linda Sun, Chih-Lin LiPharmaceutical Statistics|June 12, 2020
Bayesian optimal phase II clinical trial design with time-to-event endpointHeng Zhou, Cong Chen, Linda Sun, et al.Contemporary Clinical Trials|April 16, 2021
A novel framework of Bayesian optimal interval design for phase I trials with late-onset toxicitiesHeng Zhou, Cong Chen, Linda Sun, et al.Journal of Biomedical Informatics|September 24, 2023
ADSP: An adaptive sample pooling strategy for diagnostic testingXuekui Zhang, Xiaolin Huang, Li XingBriefings in Bioinformatics|August 20, 2025
HiCat: a semi-supervised approach for cell type annotationChang Bi, Kailun Bai, Xuekui ZhangPageof 156